OrisDX Wins 2022 New Venture Challenge with Saliva Test to Diagnose Oral Cancers
uchicago.edu
news
2022-06-03 14:59:29

Published on Friday, June 3, 2022 OrisDX wins the 2022 Edward L. Kaplan, '71, New Venture Challenge (Photo by Matt Marton)
A startup developing saliva-based diagnostics to screen for oral cancers and pre-cancers has won first place in the 26th Annual Edward L. Kaplan, '71, New Venture Challenge (NVC), the signature venture competition for MBA students at the University of Chicago Booth School of Business.
A total of $1.75 million in investment was awarded to the 11 finalist teams competing in NVC finals Thursday, the largest amount ever awarded in the history of the pioneering startup accelerator.
